Article
Washington - As the number of new cases of human immunodeficiency virus continues to grow, a topical microbicide might offer hope. Applied intravaginally, the agent has completely blocked intravaginal transmission of Simian Immunodeficiency Virus to female monkeys, according to Andrew Blauvelt, M.D.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.